A Novel Protocol for Labour Induction

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Waleed El-khayat, Cairo University
ClinicalTrials.gov Identifier:
NCT01506388
First received: January 4, 2012
Last updated: January 19, 2014
Last verified: January 2014
  Purpose

The use of foley catheter was tested many times and proved to be effective for induction of labour.


Condition Intervention Phase
Failed Induction of Labor
Device: foley catheter
Drug: Misoprostol
Drug: Vaginal IMN
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Foley Catheter Plus Vaginal Isosorbide Mononitrate Versus Vaginal Misoprostol for Induction of Labour:a Randomised Controlled Trial

Resource links provided by NLM:


Further study details as provided by Cairo University:

Primary Outcome Measures:
  • caesarean section rate [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    caesarean section


Secondary Outcome Measures:
  • time from induction to delivery [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    from the insertion of the foley catheter to delivery


Enrollment: 400
Study Start Date: February 2012
Study Completion Date: January 2014
Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: folye catheter plus vaginal IMN
intracervical foley catheter plus vaginal IMN
Device: foley catheter
foley 14 catheter intracervical plus vaginal IMN 40 mg evry 6 hours
Other Name: foley catheter
Drug: Vaginal IMN
IMN vaginal 40 mg every 4-6 hours
Other Name: Vaginal IMN
Active Comparator: Misoprostol vaginally
intravaginal misoprostol
Drug: Misoprostol
misoprostol 50 Ug , vaginally every 4-6 hours
Other Name: misoprostol vaginally

Detailed Description:

The investigators compare between vaginal misoprostol versus foley catheter plus vaginal isosorbide mononitrate (IMN) for induction of labour

  Eligibility

Ages Eligible for Study:   18 Years to 40 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Term or post term pregnancies.
  • Live,singleton fetus.
  • Cephalic presentation.
  • Intact membrane.
  • Bishop score < 6.
  • Not in labour.
  • Medically indicated for labour induction.
  • Primigravida or parity of 3 or less.

Exclusion Criteria:

  • Previous caesarean delivery.
  • Malpresentation.
  • Placenta previa.
  • Sever intrauterine growth restriction.
  • Multiple pregnancy.
  • Polyhydramnios.
  • Oligohydramnios.
  • Bishop score 7 or more.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01506388

Locations
Egypt
Cairo University
Cairo, Egypt, 12211
Waleed El-khayat
Cairo, Egypt, 12211
Sponsors and Collaborators
Cairo University
Investigators
Study Director: Waleed El-khayat, M.D. Cairo University
  More Information

No publications provided

Responsible Party: Waleed El-khayat, Principal investigator, Cairo University
ClinicalTrials.gov Identifier: NCT01506388     History of Changes
Other Study ID Numbers: 12012
Study First Received: January 4, 2012
Last Updated: January 19, 2014
Health Authority: United States: Food and Drug Administration

Keywords provided by Cairo University:
labour induction
Foley catheter
misoprostol
isosorbide mononitrate

Additional relevant MeSH terms:
Isosorbide
Isosorbide Dinitrate
Isosorbide-5-mononitrate
Misoprostol
Abortifacient Agents
Abortifacient Agents, Nonsteroidal
Anti-Ulcer Agents
Cardiovascular Agents
Diuretics
Diuretics, Osmotic
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Nitric Oxide Donors
Oxytocics
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Vasodilator Agents

ClinicalTrials.gov processed this record on October 23, 2014